Clinical Trial Update: Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 pharmacogenetic study evaluating antiarrhythmic drugs for atrial fibrillation. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Atrial Fibrillation | Phase 4 | Status: RECRUITING